Home > Research > Browse

Results for drug target

Publications & Outputs

  1. High Throughput Screens Yield Small Molecule Inhibitors of Leishmania CRK3:CYC6 Cyclin-Dependent Kinase

    Walker, R. G., Thomson, G., Malone, K., Nowicki, M. W., Brown, E., Blake, D. G., Turner, N. J., Walkinshaw, M. D., Grant, K. & Mottram, J. C., 5/04/2011, In: PLoS Neglected Tropical Diseases. 5, 4, 11 p., e1033.

    Research output: Contribution to journalJournal articlepeer-review

  2. 6-Br-5methylindirubin-3′oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: Exploitation of GSK-3 for treating leishmaniasis

    Xingi, E., Smirlis, D., Myrianthopoulos, V., Prokopios, M., Grant, K., Meijer, L., Mikros, E., Skaltsounis, A-L. & Soteriadou, K., 10/2009, In: International Journal for Parasitology. 39, 12, p. 1289-1303 15 p.

    Research output: Contribution to journalJournal articlepeer-review

  3. Trypanosomatid protein kinases as potential drug targets.

    Wiese, M., Morris, A. & Grant, K. M., 2009, Antiparasitic and antibacterial drug discovery : from molecular targets to drug candidates.. Selzer, P. M. (ed.). Weinheim: Wiley-VCH, p. 227-247 21 p. (Drug Discovery in Infectious Diseases.).

    Research output: Contribution in Book/Report/Proceedings - With ISBN/ISSNChapter